Skip to main content
Paramount Cosmetics (India) Ltd logo

Paramount Cosmetics (India) Ltd — Investor Relations & Filings

Ticker · 507970 ISIN · INE143I01013 LEI · 335800GYSH16QWY37O44 BSE.NS Manufacturing
Open in API
Filings indexed 371 across all filing types
Latest filing 2023-03-28 Regulatory Filings
Country IN India
Listing BSE.NS 507970

About Paramount Cosmetics (India) Ltd

https://parammount.com/

Paramount Cosmetics (India) Ltd specializes in the manufacturing and marketing of cosmetic and personal care products. The company is primarily recognized for its flagship brand, Shilpa, which established a significant presence in the sticker bindi market. Its product range extends to various color cosmetics, including kajal, eyeliners, and other facial grooming items. The firm emphasizes the integration of traditional beauty concepts with contemporary production standards to serve a wide consumer base. By focusing on brand development and product quality, the company maintains a portfolio of personal care solutions designed for daily use and aesthetic enhancement.

Recent filings

Filing Released Lang Actions
This is to inform that pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended by SEBI (Prohibition of Insider Trading) Amendment Regulations, 2018 ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Bombay Stock Exchange Limited informing about the closure of the trading window for designated persons in compliance with SEBI (Prohibition of Insider Trading) Regulations. It mentions the trading window closure period related to the upcoming financial results announcement but does not contain any financial data, results, or detailed report. The document is short (2291 characters) and serves as an official notification rather than a financial report or earnings release. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2023-03-28 English
With reference to captioned subject and reference, and pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we Paramount Cosmetics (India) Limited, wish to inform the Exchange that ....
Capital/Financing Update Classification · 95% confidence The document is a short communication addressed to the stock exchange (BSE Limited) informing about the credit rating assigned by CARE Ratings Ltd to the company's banking facilities. It references Regulation 30 of SEBI (LODR) Regulations, 2015, which pertains to disclosure obligations. The content is an update on credit rating, which is related to financing activities but does not detail fundraising or capital structure changes. The document length is 2058 characters, which is short and clearly an announcement rather than a detailed report. Therefore, it fits best under Capital/Financing Update (CAP) as it informs about credit rating changes affecting the company's financing profile.
2023-03-23 English
With reference to above subject, we enclose herewith 2 copies of e-Newspapers, where Standalone Un-Audited Financial Results of the Company for the Quarter & Nine Months Ended December ....
Regulatory Filings
2023-02-14 English
To considered and approved the unaudited financial results of the company for the quarter and nine months ended on December 31, 2022.
Regulatory Filings
2023-02-13 English
This is to inform you under Regulation 30, 33 and any other regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 that a meeting of the Board of Directors ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Bombay Stock Exchange regarding the outcome of a Board of Directors meeting held on February 13, 2023. It reports the approval of standalone unaudited financial results for the quarter and nine months ended December 31, 2022, along with a limited review report, and other board decisions such as issuing duplicate shares and sale of investment. The document is short (2334 characters) and serves as an announcement of board meeting outcomes rather than the full financial report itself. It references SEBI regulations and the approval of financial results but does not contain detailed financial statements or substantive financial data. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a regulatory announcement of board decisions and financial results approval, not the full report or detailed financial data.
2023-02-13 English
In Compliance with Regulation 44(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we have enclosed details regarding ....
Regulatory Filings
2023-02-07 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.